Effect of supplementation in treatment of patients with diabetic nephropathy

Phase 3

• Conditions: N08.3; Diabetic nephropathy.; Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2+)

• Registration Number: IRCT201705035623N115
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with diabetic nephropathy
Aged 40 to 80 years
Proteinuria level>0.3 g/24 h, with or without elevation of serum creatinine levels

Exclusion Criteria

History of active infection within 3 months
The intake of probiotic and/or synbiotic supplements within 3 months
Malignancy and/or liver cirrhosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.